Journal
FASEB JOURNAL
Volume 21, Issue 10, Pages 2379-2388Publisher
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.07-8213com
Keywords
immune; islet; inflammation
Categories
Funding
- Intramural NIH HHS [Z01 AA000375-02] Funding Source: Medline
- NIGMS NIH HHS [R01 GM066189-02, R01 GM66189, R01 GM066189-01, R01 GM066189] Funding Source: Medline
Ask authors/readers for more resources
Growing evidence indicates that adenosine receptors could be promising therapeutic targets in autoimmune diseases. Here we studied the role of adenosine receptors in controlling the course of type 1 diabetes. Diabetes in CD-1 mice was induced by multiple-low-dose-streptozotocin ( MLDS) treatment and in nonobese diabetic ( NOD) mice by cyclophosphamide injection. The nonselective adenosine receptor agonist 5'- N- ethylcarboxamidoadenosine ( NECA) prevented diabetes development in both MLDS-challenged mice and in cyclophosphamide-treated NOD mice. The effect of NECA was reversed by the selective A(2B) receptor antagonist N-( 4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]acetamide ( MRS 1754). The selective A(1) receptor agonist 2-chloro-N-6-cyclopentyladenosine ( CCPA) and A(3) receptor agonist N-6-( 3-iodobenzyl)-adenosine-5'-N-methyluronamide ( IB-MECA) were less efficacious in ameliorating the course of diabetes. NECA inhibited diabetes in A(2A) receptor KO mice and the selective A2A receptor agonist 2-p-(2-carboxyethyl)phenethyl-amino-5'-N-ethyl-carboxamidoadenosine ( CGS21680) had no effect in normal mice, indicating a lack of role of A2A receptors. NECA failed to prevent cytokine-induced beta-cell death in vitro, but NECA strongly suppressed expression of the proinflammatory cytokines TNF-alpha, MIP-1 alpha, IL-12, and IFN-gamma in pancreata, endotoxin, or anti-CD3-stimulated splenic cells, and T helper 1 lymphocytes, indicating that the beneficial effect of NECA was due to immunomodulation. These results demonstrate that adenosine receptor ligands are potential candidates for the treatment of type 1 diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available